Medpace Holdings, Inc. Share Price
NASDAQ: MEDP | Large CapMedpace Holdings, Inc. Stock Performance
Open $596.75 | Prev. Close $588.80 | Circuit Range N/A |
Day Range $592.92 - $602.29 | Year Range $375.00 - $677.90 | Volume 10,130 |
Average Traded $597.40 |
Medpace Holdings, Inc. Share Price Today
As of 11 August 2026, Medpace Holdings, Inc.'s share price is $602.58. The stock opened at $596.75, compared to its previous close of $588.80. During today's trading session, Medpace Holdings, Inc.'s share price traded between $592.92 and $602.29, with an average price of $597.61. Over the past 52 weeks, the stock has recorded a high of $677.90 and a low of $375.00. In terms of performance, Medpace Holdings, Inc.'s share price has risen by 33.38% over the last six months and is up 26.67% on a year-on-year basis.
Medpace Holdings, Inc. Share Price Chart
Medpace Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $17.38B | PE Ratio (TTM) 38.53 | Dividend Yield N/A |
EPS (TTM) $15.64 | Revenue (TTM) $2.53B | Return On Equity (TTM) 98.27% |
Profit Margin 17.83% | Debt to Equity 2.93 | Quarterly Earnings Growth YoY 15.25% |
Medpace Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Medpace Holdings, Inc. Annual Profit & Loss
All figures in USD
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Medpace Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $586.08 | $602.04 | +4.33% |
Jul 2026 | $534.87 | $577.05 | +8.99% |
Jun 2026 | $447.71 | $529.44 | +18.36% |
May 2026 | $421.33 | $447.31 | +6.77% |
Apr 2026 | $483.11 | $418.94 | -12.78% |
Mar 2026 | $443.33 | $480.32 | +6.32% |
Feb 2026 | $578.62 | $451.76 | -22.40% |
Jan 2026 | $558.88 | $582.16 | +3.68% |
Dec 2025 | $591.91 | $561.48 | -5.49% |
Nov 2025 | $581.81 | $594.10 | +1.65% |
Oct 2025 | $524.41 | $584.45 | +13.67% |
Sep 2025 | $470.88 | $514.14 | +8.08% |